Myelofibrosis (MF) is a group of cancers that affect your bone marrow. In these cancers, the marrow is replaced by scar tissue. This makes it hard for your body to make healthy blood cells. It is a type of chronic leukemia.
Risks for MF are:
There are no screening tests for myelofibrosis.
Signs or symptoms of myelofibrosis are due to low blood cell count(s). These can be:
Your provider will ask about your health history and do a physical exam. Blood tests like a complete blood count and peripheral blood smear will be done to check your blood counts. Molecular testing and a bone marrow biopsy will also be done.
The goal of treating myelofibrosis is to lessen the symptoms of low blood cell counts, not to cure it. This is called supportive care. Treatment is also used to help keep the disease from becoming a more aggressive type of leukemia. Treatments may be:
This article is a basic guide to myelofibrosis. You can learn more about myelofibrosis at the link below:
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania